Fig. 1From: RETRACTED ARTICLE: Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cellsHigh DLX6-AS1 expressions are observed in LCSCs and HCC cells. a, analysis of expression of DLX6-AS1 from TCGA database; b, relative expression of DLX6-AS1 in HCC tissues and adjacent normal tissues; *, p < 0.05, vs. adjacent normal tissues; c, relative expression of DLX6-AS1 in immortalized normal liver cell line and HCC cell line; *, p < 0.05, vs. the L02 cells; d, relative expression of DLX6-AS1 in non-spheroids and spheroids of LCSCs; *, p < 0.05, vs. non-spheroids; e, relative expression of DLX6-AS1 in CD133− CD13− and CD133+ CD13+ HCC cells; *, p < 0.05, vs. the CD133− CD13−; f, relationship between DLX6-AS1 expression and HCC prognosis (n = 48); the statistical data were expressed as mean value of standard error, the differences between two groups were analyzed by t test, and the others were analyzed by one-way ANOVA; ANOVA, analysis of variance; N = 48, the experiment was conducted 3 times; LCSCs, liver cancer stem cells; LncRNA, long non-coding RNA; DLX6-AS1, DLX6 antisense RNA 1; HCC, hepatocellular carcinoma; LCSCs, liver cancer stem cellsBack to article page